Pain News and Research

Latest Pain News and Research

TWi Biotechnology obtains Rare Disease Drug designation in Taiwan for use of AC-203 to treat EBS

TWi Pharmaceuticals, Inc. today announced that its fully owned subsidiary, TWi Biotechnology, Inc., has received the designation of Rare Disease Drug by Taiwan FDA for use of AC-203 to treat Epidermolysis Bullosa Simplex (EBS), and is eligible for applying for coverage under National Health Insurance Administration.

10 Mar 2015

Researchers use stem cells from sickle cell disease patients to grow mature red blood cells

Researchers at Johns Hopkins have successfully corrected a genetic error in stem cells from patients with sickle cell disease, and then used those cells to grow mature red blood cells, they report. The study represents an important step toward more effectively treating certain patients with sickle cell disease who need frequent blood transfusions and currently have few options.

10 Mar 2015

Stepped-care strategy improves function, decreases pain severity in veterans

Although U.S. military veterans who have returned from Iraq or Afghanistan are more likely to suffer chronic pain than veterans of any other conflict in American history, little headway has been made in helping them manage the often debilitating effects of chronic pain.

10 Mar 2015

18F-fluoride PET/MR imaging could diagnose cause of foot pain better than other methods

A single scan could diagnose the cause of foot pain better and with less radiation exposure to the patient than other methods, according to a study in the March 2015 issue of The Journal of Nuclear Medicine.

10 Mar 2015

Halyard Health releases improved placement kit for PEG tube

Halyard Health, formerly Kimberly-Clark Health Care, today announced the introduction of an improved placement kit for its Percutaneous Endoscopic Gastrostomy (PEG) tube, the MIC* PEG tube. The components of the kit have been organized to align with the procedural steps for tube placement.

9 Mar 2015

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

CTI BioPharma Corp. and Baxter International Inc. today announced positive top-line results for the primary endpoint from PERSIST-1, the randomized, controlled Phase 3 registration clinical trial examining pacritinib, a next generation oral JAK2/FLT3 multikinase inhibitor, for the treatment of patients with primary or secondary myelofibrosis.

From Baxter International Inc. 9 Mar 2015

BMC researchers to play key role in examining best treatment for acute low back pain

Boston Medical Center researchers are part of a national clinical trial that will examine how best to treat acute low back pain and potentially prevent it from being chronic. BMC will receive $2.3 million for its role in the five-year study that was recently approved for a $14 million award by the Patient-Centered Outcomes Research Institute.

9 Mar 2015

Obese older adults have higher rate of hospitalizations, ER admissions

Obesity is associated with substantial increases in older adults' hospitalizations, emergency room admissions and use of outpatient health care services, according to a new study of 172,866 Medicare Advantage members throughout the U.S.

9 Mar 2015

FDA approves Astellas' CRESEMBA for treatment of invasive aspergillosis, invasive mucormycosis

Astellas today announced that the U.S. Food and Drug Administration has approved its New Drug Application (NDA) for the use of CRESEMBA (isavuconazonium sulfate), the prodrug for isavuconazole, for patients 18 years of age and older in the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis).

8 Mar 2015

Researchers study safety, effectiveness of experimental Ebola vaccine following high-risk exposure

A physician who received an experimental Ebola vaccine after experiencing a needle stick while working in an Ebola treatment unit in Sierra Leone did not develop Ebola virus infection, and there was strong Ebola-specific immune responses after the vaccination, although because of its limited use to date, the effectiveness and safety of the vaccine is not certain, according to a study appearing in JAMA.

6 Mar 2015

AAPMD announces "The Silent Airway Problem: Connecting the Dots" conference

The American Academy of Physiological Medicine and Dentistry (AAPMD) is leading the charge for an interdisciplinary medical approach to the diagnosis and treatment of sleep and breathing disorders, which research indicates contribute to a range of serious physiological, cognitive, behavioral and performance conditions in children and adults.

6 Mar 2015

Non-viral gene therapy provides relief for diabetics with constant foot pain

Walking barefoot on sand "felt like walking on glass" for Keith Wenckowski, who has lived with type-one diabetes for more than two decades.

6 Mar 2015

83% of British people recognise that chronic pain is a serious medical condition, however only 15% receive proper treatment

Almost ten million people in the UK suffer from chronic pain, which has a major impact on quality of life and day to day activities, such as work; however many of those people do not have their pain under control or know how to go about seeking the right treatment.

5 Mar 2015

Good news for patients suffering from shingles

The Journal of Drugs in Dermatology is delighted to present new findings from the Mayo Clinic's Department of Dermatology showing possible relief from the complications and pain secondary to Herpes Zoster, commonly known as shingles.

5 Mar 2015

Mallinckrodt enters into definitive agreement to acquire Ikaria

Mallinckrodt plc, a leading global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held critical care company, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion.

5 Mar 2015

Valley Hospital becomes first hospital in New Jersey to use minimally-invasive approach to treat PAD

The Valley Hospital today announced it was the first hospital in New Jersey to use a recently approved device to offer a minimally-invasive approach to the treatment of peripheral artery disease (PAD) in the upper leg, a serious and common condition associated with an increased risk for heart attack and stroke.

5 Mar 2015

Accidental fentanyl exposure in children can be fatal

Infants and children are at a higher risk of accidental exposure to fentanyl patches—adhesive patches used to deliver higher doses of some opiates through the skin to relieve chronic pain.

4 Mar 2015

Restore Health Rehabilitation opens modern medical resort in Southern Maryland

Southern Maryland's first modern medical resort officially opened its doors with a ribbon-cutting ceremony on February 27.

4 Mar 2015

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Halyard Health, Inc. today reported year-end 2014 results and provided its 2015 outlook and related key planning assumptions.

4 Mar 2015

Study demonstrates that activation of cannabinoid CB2 receptors suppresses chronic pain

Medical marijuana is proliferating across the country due to the ability of cannabis ingestion to treat important clinical problems such as chronic pain. However, negative side effects and the development of tolerance limit the widespread therapeutic use of Δ9-tetrahydrocannabinol (Δ9-THC), the major psychoactive ingredient in cannabis.

4 Mar 2015

Pain News and Research

Latest Pain News and Research

TWi Biotechnology obtains Rare Disease Drug designation in Taiwan for use of AC-203 to treat EBS

Researchers use stem cells from sickle cell disease patients to grow mature red blood cells

Stepped-care strategy improves function, decreases pain severity in veterans

18F-fluoride PET/MR imaging could diagnose cause of foot pain better than other methods

Halyard Health releases improved placement kit for PEG tube

Pacritinib for myelofibrosis meets primary endpoint in Phase 3 PERSIST-1 trial

BMC researchers to play key role in examining best treatment for acute low back pain

Obese older adults have higher rate of hospitalizations, ER admissions

FDA approves Astellas' CRESEMBA for treatment of invasive aspergillosis, invasive mucormycosis

Researchers study safety, effectiveness of experimental Ebola vaccine following high-risk exposure

AAPMD announces "The Silent Airway Problem: Connecting the Dots" conference

Non-viral gene therapy provides relief for diabetics with constant foot pain

83% of British people recognise that chronic pain is a serious medical condition, however only 15% receive proper treatment

Good news for patients suffering from shingles

Mallinckrodt enters into definitive agreement to acquire Ikaria

Valley Hospital becomes first hospital in New Jersey to use minimally-invasive approach to treat PAD

Accidental fentanyl exposure in children can be fatal

Restore Health Rehabilitation opens modern medical resort in Southern Maryland

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Study demonstrates that activation of cannabinoid CB2 receptors suppresses chronic pain

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in